Concepedia

Z.H. Chi

ZC

Statistics

Publications

2

Citations

74

H-Index

2

Active since

2022

Affiliations

Peking University(Current)

Z.H. Chi is an author at Peking University specializing in surgical oncology, molecular oncology, and radiation oncology.

Top concepts

Publications per year

2022–2024

2

Publications

2

Toripalimab (anti-PD-1) versus high-dose interferon-α2b as adjuvant therapy in resected mucosal melanoma: a phase II randomized trial

Bin Lian, Lu Si, Z.H. Chi et al. · Annals of Oncology · 2022 · 37 citations

, , +9

Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase Ib/II dose-escalation and dose-expansion study

Li Zhou, Kun Yang, Shucai Zhang et al. · Annals of Oncology · 2024 · 37 citations

1–2 of 2